[癌症患者尿中免疫抑制酸性蛋白的测定]
[Determination of urinary immunosuppressive acidic protein in cancer patients].
作者信息
Hirayama T, Tamura K, Kikuchi S, Shibata Y, Kanno H, Sato Y, Ishida N, Kikuchi K
出版信息
Gan No Rinsho. 1983 Sep;29(11):1323-9.
The urine levels of immunosuppressive acidic protein (IAP) were measured in patients with and without cancer, using passive hemagglutination inhibition test and 24-h urine samples. In 23 control healthy adults, the urine levels of IAP were 0.13-1.3 mg/day. If an elevation of IAP levels were found in 46 (48%) of 96 cancer patients. Elevated urine IAP levels were found in 6 (18%) of 34 patients with non-cancerous gastrointestinal tract diseases. Increased urine IAP was demonstrated in 11 (58%) of 19 non-cancer patients with rheumatoid arthritis.
采用被动血凝抑制试验和24小时尿液样本，对患有癌症和未患癌症的患者的免疫抑制酸性蛋白（IAP）尿液水平进行了测量。在23名健康对照成年人中，IAP的尿液水平为0.13 - 1.3毫克/天。在96名癌症患者中，有46名（48%）发现IAP水平升高。在34名患有非癌性胃肠道疾病的患者中，有6名（18%）发现尿液IAP水平升高。在19名类风湿性关节炎非癌患者中，有11名（58%）显示尿液IAP升高。
Zotero 插件